ACOT13 and Hepatic steatosis: To discern whether PC-TP plays a role in Them2-induced hepatic steatosis, we utilized two loss-of-function models; a PC-TP inhibitor (14) that disrupts interaction with Them2 (8) and a newly generated skeletal muscle-specific Them2/PC-TP double knockout (S-DKO) mice.